EUVIMEDEUVIMED entdecken
Crossref

Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis

Pieter Martens iD, Sanjeeb Bhattacharya iD, Joshua Longinow iD, Lauren Ives iD, Miriam Jacob iD, Jason Valent, Mazen Hanna, W H Wilson Tang iD

Circulation: Heart Failure · 2023

DOI: 10.1161/circheartfailure.122.010078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Heart Failure, 2023. Verfasst von Pieter Martens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kaufman Center for Heart Failure Treatment and Recovery, Heart Vascular and Thoracic Institute, Cleveland Clinic, OH (P.M., S.B., L.I., M.J., M.H., W…. Hauptthemen laut MEDLINE: Heart Failure, Hypertension, Pulmonary, Amyloidosis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little information is available on the prognostic relevance of cardiac hemodynamic cutoffs in cardiac amyloidosis (CA) and its subtypes.

Methods

Consecutive patients diagnose with light chain-CA or transthyretin CA undergoing right heart catheterization were analyzed. Prognostic relevance of classic hemodynamic cutoffs of cardiac index (CI 18 mm Hg), right atrial pressure (>8 mm Hg), and mean pulmonary artery pressure (≥25 mm Hg or pulmonary hypertension) with the combined end point of cardiac transplant/left ventricular assist device and death and heart failure admissions separately was assessed.

Results

A total of 469 CA patients underwent right heart catheterization (light chain CA=42% and transthyretin CA=52%) of whom 69%, 64%, and 79% had elevated right atrial pressure, pulmonary capillary wedge pressure, and pulmonary hypertension, respectively. The classic hemodynamic cutoffs for right atrial pressure (hazard ratio, 1.26 [0.98–1.62]) and mean pulmonary artery pressure (hazard ratio, 1.28 [0.96–1.71]) did not identify patients at higher risk for adverse outcome; however, cutoffs of 14 mm Hg for right atrial pressure (hazard ratio, 1.59 [1.26–2.00]) and 35 mm Hg for mean pulmonary artery pressure (hazard ratio, 1.30 [1.01–1.66]) performed better to detect worse outcome ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHypertension, PulmonaryAmyloidosisHumansPrealbuminHemodynamicsPulmonary Wedge PressureCardiac CatheterizationPrognosis

Stichwörter der Autor:innen

amyloidosisheart failurehemodynamicspulmonary hypertension

Substanzen

Prealbumin

Autor:innen und Institutionen

  • Kaufman Center for Heart Failure Treatment and Recovery, Heart Vascular and Thoracic Institute, Cleveland Clinic, OH (P.M., S.B., L.I., M.J., M.H., W.H.W.T.).
  • Education Institute, Cleveland Clinic, OH (J.L.).
  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, OH (J.V.).

ORCID-Profile: Pieter Martens, Sanjeeb Bhattacharya, Joshua Longinow, Lauren Ives, Miriam Jacob, W H Wilson Tang

Zitieren

APA

Martens, P., Bhattacharya, S., Longinow, J., Ives, L., Jacob, M., Valent, J., Hanna, M., & Tang, W. H. W. (2023). Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.122.010078

Vancouver

Martens P, Bhattacharya S, Longinow J, Ives L, Jacob M, Valent J, et al. Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis. Circulation: Heart Failure. 2023. doi:10.1161/circheartfailure.122.010078

BibTeX
@article{Martens2023,
  author = {Martens, Pieter and Bhattacharya, Sanjeeb and Longinow, Joshua and Ives, Lauren and Jacob, Miriam and Valent, Jason and Hanna, Mazen and Tang, W H Wilson},
  title = {Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis},
  journal = {Circulation: Heart Failure},
  year = {2023},
  doi = {10.1161/circheartfailure.122.010078}
}
Kostenlos starten →